+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

France Cardiovascular Ultrasound Market by Clinical Application, Technology, Device Display, Age Group and End User: Opportunity Analysis and Industry Forecast, 2021-2030

  • PDF Icon

    Report

  • 173 Pages
  • December 2021
  • Region: France
  • Allied Market Research
  • ID: 5548457
The France cardiovascular ultrasound market was valued at $162.97 million in 2020, and is projected to reach $252.90 million by 2030, registering a CAGR of 4.7% from 2021 to 2030.



Cardiac ultrasound, or echocardiography, is a non-invasive diagnostic modality that can provide detailed hemodynamic information in a short period of time at a patient's bedside. Cardiac ultrasound should be performed with a low-frequency probe that has a small footprint that can fit between the ribs, using a cardiac setting. It is a non-invasive, rapid, and inexpensive application that expedites diagnosis and management of imminently life-threatening diseases, including pericardial tamponade, acute coronary syndrome, cardiomyopathy, pulmonary embolism, and Stanford type-A aortic dissection. It can also differentiate shock states and guide resuscitative measures. It must be performed by inter-professional team and nurses should be prepared to assist the provider in point-of-care ultrasound applications.

The key factors that boost the growth of the France cardiovascular ultrasound market include increased advantages of echocardiography over invasive cardiac diagnostic procedures and increase in incidence of cardiovascular diseases (CVDs). In addition, this technology is widely accepted among patients as it is non-invasive, hence shortens the stay at hospitals, which fuels the market growth. However, factors such as economic influence of approving new technologies and insufficient reimbursement scenario impede the growth of the market. Conversely, technological advancements leading in cardiac specific technologies such as tissue enhancements, lateral gain control, advanced dynamic flow, tissue Doppler, and stress echo provide lucrative opportunities for the growth of the market.

The France cardiovascular ultrasound market is segmented into clinical application, technology, device display, age group, and end user. On the basis of clinical application, the market is categorized into diagnostic cardiology, interventional cardiology, and vascular diagnostic. Diagnostic cardiology is further categorized as transthoracic echocardiogram, transesophageal echocardiogram, stress echocardiogram, and other echocardiogram. Interventional cardiology is further categorized as electrophysiology procedure, septal closure procedure and others. Vascular diagnostic is further categorized as aortoiliac duplex, carotid duplex, lower extremity arterial duplex, iliocaval duplex, and mesenteric duplex. By technology, it is classified into 2D, 3D & 4D, and Doppler imaging. By device display, it is classified into color display and black &white display. By age group, it is classified into adult and pediatric. By end user, it is classified into private clinics, public hospitals, cardiology centers, and ambulatory centers.

KEY BENEFITS FOR STAKEHOLDERS

  • This report provides a detailed quantitative analysis of the current market trends and future estimations from 2020 to 2030, which assists to identify the prevailing market opportunities.
  • An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
  • A comprehensive analysis of the factors that drive and restrain the growth of the France cardiovascular ultrasound market is provided.
  • An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.

KEY MARKET SEGMENTS


By Clinical Application

  • Diagnostic Cardiology
  • Transthoracic Echocardiogram
  • Transesophageal Echocardiogram
  • Stress Echocardiogram
  • Other Echocardiogram
  • Interventional Cardiology
  • Electrophysiology Procedure
  • Septal Closure Procedure
  • Others
  • Vascular Diagnostics
  • Aortoiliac Duplex,
  • Carotid Duplex,
  • Lower Extremity Arterial Duplex,
  • Iliocaval Duplex
  • Mesenteric Duplex

By Technology

  • 2D
  • 3D & 4D
  • Doppler Imaging

By Device Display

  • Colour Display
  • Black and White Display

By Age Group

  • Adult
  • Paediatric

By End User

  • Private Clinics
  • Diagnostic Cardiology
  • Interventional Cardiology
  • Vascular Diagnostics
  • Public Hospitals
  • Diagnostic Cardiology
  • Interventional Cardiology
  • Vascular Diagnostics
  • Cardiology Centres
  • Diagnostic Cardiology
  • Interventional Cardiology
  • Vascular Diagnostics
  • Ambulatory Centres
  • Diagnostic Cardiology
  • Interventional Cardiology
  • Vascular Diagnostics

KEY MARKET PLAYERS

  • Canon Inc. (Canon Medical System Corporation)
  • Esaote S.p.A
  • Fujifilm Holding Corporation
  • General Electric Company
  • Hitachi Ltd
  • Koninklijke Philips N.V.
  • Mindray Medical International Limited
  • Samsung Group
  • Siemens AG
  • SuperSonic Imagine
Frequently Asked Questions about the French Cardiovascular Ultrasound Market

What is the estimated value of the French Cardiovascular Ultrasound Market?

The French Cardiovascular Ultrasound Market was estimated to be valued at $162.97 million in 2020.

What is the growth rate of the French Cardiovascular Ultrasound Market?

The growth rate of the French Cardiovascular Ultrasound Market is 4.5%, with an estimated value of $252.9 million by 2030.

What is the forecasted size of the French Cardiovascular Ultrasound Market?

The French Cardiovascular Ultrasound Market is estimated to be worth $252.9 million by 2030.

Who are the key companies in the French Cardiovascular Ultrasound Market?

Key companies in the French Cardiovascular Ultrasound Market include Canon Inc. (Canon Medical System Corporation), Esaote S.p.A, Fujifilm Holding Corporation, General Electric Company, Hitachi Ltd, Koninklijke Philips N.V., Mindray Medical International Limited, Samsung Group and SuperSonic Imagine.

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key Benefits for Stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Porter’s five force analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in incidence of cardiovascular diseases (CVDs)
3.4.1.2. Advantages of echocardiography over invasive cardiac diagnostic procedures
3.4.1.3. Increase in geriatric population
3.4.2. Restraint
3.4.2.1. Stringent government regulations
3.4.3. Opportunities
3.4.3.1. Technological advancements in cardiovascular ultrasound systems
3.4.4. Impact analysis
3.5. COVID-19 Impact Analysis on France cardiovascular ultrasound Market
CHAPTER 4: FRANCE CARDIOVASCULAR ULTRASOUND MARKET, BY CLINICAL APPLICATION
4.1. Overview
4.1.1. Market size and forecast
4.2. Diagnostic Cardiology
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast
4.2.3. Market size and forecast, by test type
4.2.3.1. Transthoracic Echocardiogram
4.2.3.1.1. Market size and forecast
4.2.3.2. Transesophageal Echocardiogram
4.2.3.2.1. Market size and forecast
4.2.3.3. Stress Echocardiogram
4.2.3.3.1. Market size and forecast
4.2.3.4. Other Echocardiogram
4.2.3.4.1. Market size and forecast
4.3. Interventional Cardiology
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.3.3. Market size and forecast, by test type
4.3.3.1. Electrophysiology procedure
4.3.3.1.1. Market size and forecast
4.3.3.2. Septal closure procedure
4.3.3.2.1. Market size and forecast
4.3.3.3. Others
4.3.3.3.1. Market size and forecast
4.4. Vascular Diagnostic
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast
4.4.3. Market size and forecast, by test type
4.4.3.1. Aortoiliac Duplex
4.4.3.1.1. Market size and forecast
4.4.3.2. Carotid Duplex
4.4.3.2.1. Market size and forecast
4.4.3.3. Lower Extremity Arterial Duplex
4.4.3.3.1. Market size and forecast
4.4.3.4. Iliocaval Duplex
4.4.3.4.1. Market size and forecast
4.4.3.5. Mesenteric Duplex
4.4.3.5.1. Market size and forecast
CHAPTER 5: FRANCE CARDIOVASCULAR ULTRASOUND MARKET, BY TECHNOLOGY
5.1. Overview
5.1.1. Market size and forecast
5.2.2D
5.2.1. Market size and forecast
5.3.3D& 4D
5.3.1. Market size and forecast
5.4. Doppler Imaging
5.4.1. Market size and forecast
CHAPTER 6: FRANCE CARDIOVASCULAR ULTRASOUND MARKET, BY DEVICE DISPLAY
6.1. Overview
6.1.1. Market size and forecast
6.2. Color Display
6.2.1. Market size and forecast
6.3. Black &White Display
6.3.1. Market size and forecast
CHAPTER 7: FRANCE CARDIOVASCULAR ULTRASOUND MARKET, BY AGE GROUP
7.1. Overview
7.1.1. Market size and forecast
7.2. Adult
7.2.1. Market size and forecast
7.3. Pediatric
7.3.1. Market size and forecast
CHAPTER 8: FRANCE CARDIOVASCULAR ULTRASOUND MARKET, BY END USER
8.1. Overview
8.1.1. Market size and forecast
8.2. Private Clinics
8.2.1. Market size and forecast
8.2.2. Market size and forecast, by clinical application
8.2.2.1. Diagnostic cardiology
8.2.2.1.1. Market size and forecast
8.2.2.2. Interventional cardiology
8.2.2.2.1. Market size and forecast
8.2.2.3. Vascular diagnostic
8.2.2.3.1. Market size and forecast
8.3. Public Hospitals
8.3.1. Market size and forecast
8.3.2. Market size and forecast, by clinical application
8.3.2.1. Diagnostic cardiology
8.3.2.1.1. Market size and forecast
8.3.2.2. Interventional cardiology
8.3.2.2.1. Market size and forecast
8.3.2.3. Vascular diagnostic
8.3.2.3.1. Market size and forecast
8.4. Cardiology centers
8.4.1. Market size and forecast
8.4.2. Market size and forecast, by clinical application
8.4.2.1. Diagnostic cardiology
8.4.2.1.1. Market size and forecast
8.4.2.2. Interventional cardiology
8.4.2.2.1. Market size and forecast
8.4.2.3. Vascular diagnostic
8.4.2.3.1. Market size and forecast
8.5. Ambulatory centers
8.5.1. Market size and forecast
8.5.2. Market size and forecast, by clinical application
8.5.2.1. Diagnostic cardiology
8.5.2.1.1. Market size and forecast
8.5.2.2. Interventional cardiology
8.5.2.2.1. Market size and forecast
8.5.2.3. Vascular diagnostic
8.5.2.3.1. Market size and forecast
CHAPTER 9: COMPANY PROFILES
9.1. CANON INC. (CANON MEDICAL SYSTEM CORPORATION)
9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Product portfolio
9.1.5. Business performance
9.1.6. Key strategic moves and developments
9.2. ESAOTE S.P.A
9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Product portfolio
9.2.5. Key strategic moves and developments
9.3. FUJIFILM HOLDING CORPORATION
9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Product portfolio
9.3.5. Business performance
9.4. GENERAL ELECTRIC COMPANY
9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Product portfolio
9.4.5. Business performance
9.5. HITACHI LTD.
9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Product portfolio
9.5.5. Business performance
9.6. KONINKLIJKE PHILIPS N.V.
9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Product portfolio
9.6.5. Business performance
9.6.6. Key strategic moves and developments
9.7. MINDRAY MEDICAL INTERNATIONAL LIMITED
9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Product portfolio
9.8. SAMSUNG GROUP
9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Product portfolio
9.8.5. Business performance
9.9. SIEMENS AG
9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Product portfolio
9.9.5. Business performance
9.10. SUPERSONIC IMAGINE
9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Product portfolio
9.10.5. Business performance
List of Tables
TABLE 01. FRANCE CARDIOVASCULAR ULTRASOUND MARKET, BY CLINICAL APPLICATION, 2020-2030 ($MILLION)
TABLE 02. FRANCE CARDIOVASCULAR ULTRASOUND MARKET FOR DIAGNOSTIC CARDIOLOGY, BY TEST TYPE 2020-2030 ($MILLION)
TABLE 03. FRANCE CARDIOVASCULAR ULTRASOUND MARKET FOR INTERVENTIONAL CARDIOLOGY, BY TEST TYPE 2020-2030 ($MILLION)
TABLE 04. FRANCE CARDIOVASCULAR ULTRASOUND MARKET FOR VASCULAR DIAGNOSTIC, BY TEST TYPE 2020-2030 ($MILLION)
TABLE 05. FRANCE CARDIOVASCULAR ULTRASOUND MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 06. FRANCE CARDIOVASCULAR ULTRASOUND MARKET, BY DEVICE DISPLAY, 2020-2030 ($MILLION)
TABLE 07. FRANCE CARDIOVASCULAR ULTRASOUND MARKET, BY AGE GROUP, 2020-2030 ($MILLION)
TABLE 08. FRANCE CARDIOVASCULAR ULTRASOUND MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 09. FRANCE CARDIOVASCULAR ULTRASOUND MARKET FOR PRIVATE CLINICS, BY CLINICAL APPLICATION 2020-2030 ($MILLION)
TABLE 10. FRANCE CARDIOVASCULAR ULTRASOUND MARKET FOR PUBLIC HOSPITALS, BY CLINICAL APPLICATION 2020-2030 ($MILLION)
TABLE 11. FRANCE CARDIOVASCULAR ULTRASOUND MARKET FOR CARDIOLOGY CENTERS, BY CLINICAL APPLICATION 2020-2030 ($MILLION)
TABLE 12. FRANCE CARDIOVASCULAR ULTRASOUND MARKET FOR AMBULATORY CENTERS, BY CLINICAL APPLICATION 2020-2030 ($MILLION)
TABLE 13. CANON: COMPANY SNAPSHOT
TABLE 14. CANON: OPERATING SEGMENTS
TABLE 15. CANON: PRODUCT PORTFOLIO
TABLE 16. CANON: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 17. ESAOTE: COMPANY SNAPSHOT
TABLE 18. ESAOTE: OPERATING SEGMENTS
TABLE 19. ESAOTE: PRODUCT PORTFOLIO
TABLE 20. ESAOTE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 21. FUJIFILM: COMPANY SNAPSHOT
TABLE 22. FUJIFILM: OPERATING SEGMENTS
TABLE 23. FUJIFILM: PRODUCT PORTFOLIO
TABLE 24. GENERAL ELECTRIC: COMPANY SNAPSHOT
TABLE 25. GENERAL ELECTRIC: OPERATING SEGMENTS
TABLE 26. GENERAL ELECTRIC: PRODUCT PORTFOLIO
TABLE 27. HITACHI: COMPANY SNAPSHOT
TABLE 28. HITACHI: OERATING SEGMENT
TABLE 29. HITACHI.: PRODUCT PORTFOLIO
TABLE 30. PHILLIPS: COMPANY SNAPSHOT
TABLE 31. PHILLIPS: OPERATING SEGMENTS
TABLE 32. PHILLIPS: PRODUCT PORTFOLIO
TABLE 33. PHILLIPS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 34. MINDRAY: COMPANY SNAPSHOT
TABLE 35. MINDRAY: OPERATING SEGMENTS
TABLE 36. MINDRAY: PRODUCT PORTFOLIO
TABLE 37. SAMSUNG: COMPANY SNAPSHOT
TABLE 38. SAMSUNG: OPERATING SEGMENTS
TABLE 39. SAMSUNG: PRODUCT PORTFOLIO
TABLE 40. SIEMENS: COMPANY SNAPSHOT
TABLE 41. SIEMENS: OPERATING SEGMENTS
TABLE 42. SIEMENS: PRODUCT PORTFOLIO
TABLE 43. SUPERSONIC: COMPANY SNAPSHOT
TABLE 44. SUPERSONIC: OPERATING SEGMENTS
TABLE 45. SUPERSONIC: PRODUCT PORTFOLIO
List of Figures
FIGURE 01. FRANCE CARDIOVASCULAR ULTRASOUND MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2018-2021
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018-2021
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2018-2021
FIGURE 06. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07. MODERATE BARGAINING POWER OF BUYERS
FIGURE 08. MODERATE THREAT OF SUBSTITUTES
FIGURE 09. MODERATE THREAT OF NEW ENTRANTS
FIGURE 10. HIGH INTENSITY OF RIVALRY
FIGURE 11. IMPACT ANALYSIS
FIGURE 12. FRANCE CARDIOVASCULAR ULTRASOUND MARKET FOR DIAGNOSTIC CARDIOLOGY, 2020-2030 ($MILLION)
FIGURE 13. FRANCE TRANSTHORACIC ECHOCARDIOGRAM MARKET, 2020-2030 ($MILLION)
FIGURE 14. FRANCE TRANSESOPHAGEAL ECHOCARDIOGRAM MARKET, 2020-2030 ($MILLION)
FIGURE 15. FRANCE STRESS ECHOCARDIOGRAM MARKET, 2020-2030 ($MILLION)
FIGURE 16. FRANCE OTHER ECHOCARDIOGRAM MARKET, 2020-2030 ($MILLION)
FIGURE 17. FRANCE CARDIOVASCULAR ULTRASOUND MARKET FOR INTERVENTIONAL CARDIOLOGY, 2020-2030 ($MILLION)
FIGURE 18. FRANCE ELECTROPHYSIOLOGY PROCEDURES MARKET, 2020-2030 ($MILLION)
FIGURE 19. FRANCE SEPTAL CLOSURE PROCEDURE MARKET, 2020-2030 ($MILLION)
FIGURE 20. FRANCE OTHERS SMARKET, 2020-2030 ($MILLION)
FIGURE 21. FRANCE CARDIOVASCULAR ULTRASOUND MARKET FOR VASCULAR DIAGNOSTIC, 2020-2030 ($MILLION)
FIGURE 22. FRANCE AORTOILIAC DUPLEX MARKET, 2020-2030 ($MILLION)
FIGURE 23. FRANCE CAROTID DUPLEX MARKET, 2020-2030 ($MILLION)
FIGURE 24. FRANCE LOWER EXTREMITY ARTERIAL DUPLEX MARKET, 2020-2030 ($MILLION)
FIGURE 25. FRANCE ILIOCAVAL DUPLEX MARKET, 2020-2030 ($MILLION)
FIGURE 26. FRANCE MESENTERIC DUPLEX MARKET, 2020-2030 ($MILLION)
FIGURE 27. FRANCE 2D CARDIOVASCULAR ULTRASOUND MARKET, 2020-2030 ($MILLION)
FIGURE 28. FRANCE 3D & 4D CARDIOVASCULAR ULTRASOUND MARKET, 2020-2030 ($MILLION)
FIGURE 29. FRANCE DOPPLER IMAGING CARDIOVASCULAR ULTRASOUND MARKET, 2020-2030 ($MILLION)
FIGURE 30. FRANCE COLOR DISPLAY CARDIOVASCULAR ULTRASOUND MARKET, 2020-2030 ($MILLION)
FIGURE 31. FRANCE BLACK & WHITE DISPLAYCARDIOVASCULAR ULTRASOUND MARKET, 2020-2030 ($MILLION)
FIGURE 32. FRANCE CARDIOVASCULAR ULTRASOUND MARKET FOR ADULT, 2020-2030 ($MILLION)
FIGURE 33. FRANCE CARDIOVASCULAR ULTRASOUND MARKET, FOR PEDIATRIC, 2020-2030 ($MILLION)
FIGURE 34. FRANCE CARDIOVASCULAR ULTRASOUND MARKET FOR PRIVATE CLINICS, 2020-2030 ($MILLION)
FIGURE 35. FRANCE DIAGNOSTIC CARDIOLOGY CARDIOVASCULAR ULTRASOUND MARKET FOR PRIVATE CLINICS, 2020-2030 ($MILLION)
FIGURE 36. FRANCE INTERVENTIONAL CARDIOLOGY CARDIOVASCULAR ULTRASOUND MARKET FOR PRIVATE CLINICS, 2020-2030 ($MILLION)
FIGURE 37. FRANCE VASCULAR DIAGNOSTIC CARDIOVASCULAR ULTRASOUND MARKETFOR PRIVATE CLINICS, 2020-2030 ($MILLION)
FIGURE 38. FRANCE CARDIOVASCULAR ULTRASOUND MARKET FOR PUBLIC HOSPITALS, 2020-2030 ($MILLION)
FIGURE 39. FRANCE DIAGNOSTIC CARDIOLOGY CARDIOVASCULAR ULTRASOUND MARKET FOR PUBLIC HOSPITALS, 2020-2030 ($MILLION)
FIGURE 40. FRANCE INTERVENTIONAL CARDIOLOGY CARDIOVASCULAR ULTRASOUND MARKET FOR PUBLIC HOSPITALS, 2020-2030 ($MILLION)
FIGURE 41. FRANCE VASCULAR DIAGNOSTIC CARDIOVASCULAR ULTRASOUND MARKET FOR PUBLIC HOSPITALS, 2020-2030 ($MILLION)
FIGURE 42. FRANCE CARDIOVASCULAR ULTRASOUND MARKET FOR CARDIOLOGY CENTERS , 2020-2030 ($MILLION)
FIGURE 43. FRANCE DIAGNOSTIC CARDIOLOGY CARDIOVASCULAR ULTRASOUND MARKET FOR CARDIOLOGY CENTERS, 2020-2030 ($MILLION)
FIGURE 44. FRANCE INTERVENTIONAL CARDIOLOGY CARDIOVASCULAR ULTRASOUND MARKET FOR CARDIOLOGY CENTERS, 2020-2030 ($MILLION)
FIGURE 45. FRANCE VASCULAR DIAGNOSTIC CARDIOVASCULAR ULTRASOUND MARKET FOR CARDIOLOGY CENTERS, 2020-2030 ($MILLION)
FIGURE 46. FRANCE CARDIOVASCULAR ULTRASOUND MARKET FOR AMBULATORY CENTERS, 2020-2030 ($MILLION)
FIGURE 47. FRANCE DIAGNOSTIC CARDIOLOGY CARDIOVASCULAR ULTRASOUND MARKET FOR AMBULATORY CENTERS, 2020-2030 ($MILLION)
FIGURE 48. FRANCE INTERVENTIONAL CARDIOLOGY CARDIOVASCULAR ULTRASOUND MARKET FOR AMBULATORY CENTERS, 2020-2030 ($MILLION)
FIGURE 49. FRANCE VASCULAR DIAGNOSTIC CARDIOVASCULAR ULTRASOUND MARKET FOR AMBULATORY CENTERS, 2020-2030 ($MILLION)
FIGURE 50. CANON: NET SALES, 2018-2020 ($MILLION)
FIGURE 51. CANON: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 52. CANON: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 53. FUJIFILM: NET SALES, 2018-2020 ($MILLION)
FIGURE 54. FUJIFILM: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 55. GENERAL ELECTRIC: NET SALES, 2018-2020 ($MILLION)
FIGURE 56. GENERAL ELECTRIC: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 57. GENERAL ELECTRIC: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 58. HITACHI: NET SALES, 2018-2020 ($MILLION)
FIGURE 59. HITACHI: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 60. HITACHI: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 61. PHILLIPS: NET SALES, 2018-2020 ($MILLION)
FIGURE 62. PHILLIPS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 63. PHILLIPS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 64. SAMSUNG: NET SALES, 2018-2020 ($MILLION)
FIGURE 65. SIEMENS: NET SALES, 2019-2021 ($MILLION)
FIGURE 66. SIEMENS: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 67. SIEMENS: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 68. SUPERSONIC: NET SALES, 2018-2020 ($MILLION)
FIGURE 69. SUPERSONIC: REVENUE SHARE BY SEGMENT, 2021 (%)

Companies Mentioned

  • Canon Inc. (Canon Medical System Corporation)
  • Esaote S.p.A
  • Fujifilm Holding Corporation
  • General Electric Company
  • Hitachi Ltd
  • Koninklijke Philips N.V.
  • Mindray Medical International Limited
  • Samsung Group
  • Siemens AG
  • SuperSonic Imagine

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...